Specific inhibition of HIV-1 protease by boronated porphyrins.
DeCamp
D L
DL
Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco 94143-0446.
Babé
L M
LM
Salto
R
R
Lucich
J L
JL
Koo
M S
MS
Kahl
S B
SB
Craik
C S
CS
D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors; D001895:Boron / Q000494:pharmacology; D016333:HIV Protease; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology*; D011166:Porphyrins / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D011166:Porphyrins; D011480:Protease Inhibitors; D016282:Aspartic Acid Endopeptidases; D016333:HIV Protease; C065184:p16 protease, Human immunodeficiency virus 2; D001895:Boron